Aller au contenu

LEO Pharma Signs Agreement to Divest Emollients and Proctology Portfolio to Karo Pharma

Ballerup, DENMARK, December 23, 2019 – LEO Pharma announced the sale of 10 products to Karo Pharma AB for 90 MEUR. The divested portfolio is non-core to LEO Pharma's business, and was part of the portfolio acquired from Bayer in July 2019.
Read the full story
Error while rendering view [NewsList]. The rendering is lacking some configuration. Please, read description below and try to fix the problem.

Meet our Global Leadership Team

The Global Leadership Team is responsible for overall business growth, strategic direction and daily operations.

We pursue an open and active dialogue with the media

We believe in making our activities and operations accessible to all relevant media

Henrik Kyndlev

Director, Global External Communications
Tel: +45 3140 6180